Bio€quity Europe 2017

Publié le 17/01/2017

22-23 May, 2017

Paris, France

Bio€quity Europe pioneered the turf-neutral concept, creating an open door for all members of the financial community and business development and licensing professionals to do business with independently selected Presenting Companies.

Now celebrating its 18th meeting, Bio€quity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects. Bio€quity Europe has showcased more than 700 leading European companies to thousands of investment and pharma business development professionals. Delegates from over 20 nations attended Bio€quity Europe last year.

http://www.biocentury.com/conferences/bioequityeurope/dates>

• J.P. Morgan week et WuXi Global Forum 2025 à San Francisco
• 4th Rare & Genetic Kidney Disease Drug Development Summit
• MOSAIC - Global NASH Trialist Forum 2024
• The 2024 international workshop on Alport syndrome
• Alport Connect 2024, la rencontre annuelle américaine avec les patients atteints du syndrome d’Alport